
November 13, 2017 - By wolcottdaily
Dodge & Cox decreased its stake in Novartis Ag (NVS) by 0.87% based on its latest 2017Q2 regulatory filing with the SEC. Dodge & Cox sold 442,281 shares as the company’s stock rose 4.17% with the market. The institutional investor held 50.14M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $4.19B, down from 50.59 million at the end of the previous reported quarter. Dodge & Cox who had been investing in Novartis Ag for a number of months, seems to be less bullish one the $216.07 billion market cap company. The stock rose 0.50% or $0.41 reaching $82.79. About 770,582 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 13, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.Dodge & Cox, which manages about $118.58 billion US Long portfolio, upped its stake in Johnson Controls International by 26.32M shares to 57.85 million shares, valued at $2.51B in 2017Q2, according to the filing. It also increased its holding in Liberty Global Plc (NASDAQ:LBTYA) by 2.83M shares in the quarter, for a total of 18.98 million shares, and has risen its stake in Hewlett Packard Enterprise Co. Investors wait Novartis AG (ADR) (NYSE:NVS) to report on January, 24. its quarterly earnings Wall Street analysts expect $1.16 earnings per share, up $0.04 or 3.57 % from last year’s $1.12 same quarter earnings. This translates into $3.03B profit for NVS giving the stock a 17.84 P/E. This is assuming the current $1.16 EPS is accurate. Novartis AG (ADR)’s Wall Street analysts see -10.08 % negative EPS growth, taking into account the $1.29 EPS reproted in the previous quarter, Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of NVS in report on Monday, July 10 with “Hold” rating. Cowen & Co maintained it with “Hold” rating and $90.0 target in Monday, September 11 report. The stock has “Sell” rating by Barclays Capital on Wednesday, October 25. As per Thursday, June 22, the company rating was maintained by Leerink Swann. Argus Research upgraded the shares of NVS in report on Thursday, November 10 to “Buy” rating. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Underperform” rating by Credit Suisse on Wednesday, July 5. The rating was maintained by Cowen & Co on Wednesday, August 9 with “Hold”. The firm has “Hold” rating by Argus Research given on Tuesday, April 5. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Hold” rating by Cowen & Co on Friday, October 13. The firm earned “Overweight” rating on Wednesday, July 26 by Morgan Stanley.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
